Cerebral Amyloid Angiopathy
New England Journal of Medicine · 07.05.2026 · 394 (18) · 1836-1845
DOI: 10.1056/nejmra2411298 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 07.05.2026. Verfasst von Steven M Greenberg. Beteiligte Einrichtung: J. Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Cognitive Dysfunction, Hemorrhagic Stroke. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Cerebral amyloid angiopathy is a major cause of hemorrhagic stroke, a frequent contributor to age-related cognitive impairment, and a key component in adverse responses to beta-amyloid (Aβ) immunotherapy. Defined by pathological deposition of Aβ in the small blood vessels of the brain, cerebral amyloid angiopathy is most often diagnosed on the basis of magnetic resonance imaging studies showing multiple hemorrhages or leptomeningeal blood products within or overlying the cerebral cortex. The disorder typically manifests as hemorrhagic stroke or as a contributing factor to cognitive decline and, less commonly, with transient focal neurologic symptoms or a cerebral inflammatory autoimmune syndrome. The high risk of recurrent hemorrhagic strokes associated with cerebral amyloid angiopathy poses a particular challenge in patients with indications for antithrombotic therapy and dictates a carefully individualized weighing of risks and benefits. Ongoing research is focused on tools to aid in risk prediction, early diagnostic markers, and identification of key pathogenic steps as targets for disease-modifying therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- J. Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Boston.
- Harvard Medical School, Boston.
ORCID-Profile: Steven M Greenberg
Zitieren
APA
Greenberg, S. M. (2026). Cerebral Amyloid Angiopathy. New England Journal of Medicine, 394(18), 1836-1845. https://doi.org/10.1056/nejmra2411298
Vancouver
Greenberg SM. Cerebral Amyloid Angiopathy. New England Journal of Medicine. 2026;394(18):1836-1845. doi:10.1056/nejmra2411298
BibTeX
@article{Greenberg2026,
author = {Greenberg, Steven M},
title = {Cerebral Amyloid Angiopathy},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {18},
pages = {1836--1845},
doi = {10.1056/nejmra2411298}
}
EUVIMED